208 related articles for article (PubMed ID: 21410686)
1. A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
Mixcoatl-Zecuatl T; Jolivalt CG
Br J Pharmacol; 2011 Sep; 164(1):159-69. PubMed ID: 21410686
[TBL] [Abstract][Full Text] [Related]
2. The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration.
Sun YH; Li HS; Zhu C; Hu W; Yang J; Zhao GL; Lu GJ; Wu SX; Dong YL
Neurosci Lett; 2014 May; 568():6-11. PubMed ID: 24686187
[TBL] [Abstract][Full Text] [Related]
3. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 2A and 2B receptor-induced phrenic motor facilitation: differential requirement for spinal NADPH oxidase activity.
MacFarlane PM; Vinit S; Mitchell GS
Neuroscience; 2011 Mar; 178():45-55. PubMed ID: 21223996
[TBL] [Abstract][Full Text] [Related]
5. AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy.
Murai N; Aoki T; Tamura S; Yamamoto H; Hamakawa N; Matsuoka N
Neuropharmacology; 2014 Apr; 79():10-6. PubMed ID: 24211301
[TBL] [Abstract][Full Text] [Related]
6. Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation.
Raote I; Bhattacharyya S; Panicker MM
Mol Pharmacol; 2013 Jan; 83(1):42-50. PubMed ID: 23034456
[TBL] [Abstract][Full Text] [Related]
7. Disruption of 5-HT
Wattiez AS; Dupuis A; Privat AM; Chalus M; Chapuy E; Aissouni Y; Eschalier A; Courteix C
Neuropharmacology; 2017 Oct; 125():308-318. PubMed ID: 28780039
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Fone KC; Robinson AJ; Marsden CA
Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the participation of peripheral 5-HT₂A, 5-HT₂B, and 5-HT₂C receptors in formalin-induced secondary mechanical allodynia and hyperalgesia.
Cervantes-Durán C; Pineda-Farias JB; Bravo-Hernández M; Quiñonez-Bastidas GN; Vidal-Cantú GC; Barragán-Iglesias P; Granados-Soto V
Neuroscience; 2013 Mar; 232():169-81. PubMed ID: 23219842
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
Hadamitzky M; Feja M; Becker T; Koch M
Behav Pharmacol; 2009 Sep; 20(5-6):415-23. PubMed ID: 19730369
[TBL] [Abstract][Full Text] [Related]
11. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ketanserin in rats.
Wang D; Chen T; Gao Y; Quirion R; Hong Y
Pharmacol Biochem Behav; 2012 May; 101(3):379-86. PubMed ID: 22342663
[TBL] [Abstract][Full Text] [Related]
13. [Effects of blockade of 5-HT2A receptors in inflammatory site on complete Freund's adjuvant-induced chronic hyperalgesia and neuropeptide Y expression in the spinal dorsal horn in rats].
Huang BQ; Wu B; Hong Y; Hu W
Sheng Li Xue Bao; 2015 Oct; 67(5):463-9. PubMed ID: 26490063
[TBL] [Abstract][Full Text] [Related]
14. Serotonin (5-HT)2A/2C receptor agonist (2,5-dimethoxy-4-idophenyl)-2-aminopropane hydrochloride (DOI) improves voiding efficiency in the diabetic rat.
Tu H; Cao N; Gu B; Si J; Chen Z; Andersson KE
BJU Int; 2015 Jul; 116(1):147-55. PubMed ID: 25822577
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic mechanism of the relieving effect of bee venom acupuncture on oxaliplatin-induced neuropathic cold allodynia in rats.
Lee JH; Li DX; Yoon H; Go D; Quan FS; Min BI; Kim SK
BMC Complement Altern Med; 2014 Dec; 14():471. PubMed ID: 25481535
[TBL] [Abstract][Full Text] [Related]
16. Diabetes inhibits the DOI-induced head-twitch response in mice.
Miyata S; Hirano S; Kamei J
Psychopharmacology (Berl); 2004 Dec; 177(1-2):224-9. PubMed ID: 15290007
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
Bektas N; Arslan R; Ozturk Y
Life Sci; 2014 Jan; 95(1):9-13. PubMed ID: 24361360
[TBL] [Abstract][Full Text] [Related]
18. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of fluvoxamine attenuates neuropathic pain and involvement of spinal serotonin receptors in diabetic model rats.
Kato T; Kajiyama S; Hamada H; Kawamoto M
Hiroshima J Med Sci; 2013 Dec; 62(4):83-9. PubMed ID: 24597211
[TBL] [Abstract][Full Text] [Related]
20. Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.
Marshall AG; Lee-Kubli C; Azmi S; Zhang M; Ferdousi M; Mixcoatl-Zecuatl T; Petropoulos IN; Ponirakis G; Fineman MS; Fadavi H; Frizzi K; Tavakoli M; Jeziorska M; Jolivalt CG; Boulton AJM; Efron N; Calcutt NA; Malik RA
Diabetes; 2017 May; 66(5):1380-1390. PubMed ID: 28202580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
